Role of environmental poliovirus surveillance in global polio eradication and beyond

被引:214
作者
Hovi, T. [1 ]
Shulman, L. M. [2 ]
Van der Avoort, H. [3 ]
Deshpande, J. [4 ]
Roivainen, M. [1 ]
De Gourville, E. M. [5 ]
机构
[1] Natl Inst Hlth & Welf THL, Helsinki 00271, Finland
[2] Chaim Sheba Med Ctr, Minist Hlth, CVL, IL-52621 Tel Hashomer, Israel
[3] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands
[4] ERC, Bombay, Maharashtra, India
[5] WHO, Global Poliomyelitis Eradicat Initiat, CH-1211 Geneva, Switzerland
关键词
Infectious disease epidemiology; polio; polio vaccine virus; public health; surveillance; VACCINE-DERIVED POLIOVIRUS; POLIOMYELITIS OUTBREAK; SEWAGE; WILD; CIRCULATION; TYPE-3; RISKS; WATER; TRANSMISSION; SPECIMENS;
D O I
10.1017/S095026881000316X
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Environmental poliovirus surveillance (ENV) means monitoring of poliovirus (PV) transmission in human populations by examining environmental specimens supposedly contaminated by human faeces. The rationale is based on the fact that PV-infected individuals, whether presenting with disease symptoms or not, shed large amounts of PV in the faeces for several weeks. As the morbidity: infection ratio of PV infection is very low, this fact contributes to the sensitivity of ENV which under optimal conditions can be better than that of the standard acute flaccid paralysis (AFP) surveillance. The World Health Organization has included ENV in the new Strategic Plan of the Global Polio Eradication Initiative for years 2010-2012 to be increasingly used in PV surveillance, supplementing AFP surveillance. In this paper we review the feasibility of using ENV to monitor wild PV and vaccine-derived PV circulation in human populations, based on global experiences in defined epidemiological situations.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 49 条
[1]  
[Anonymous], 2003, Vacc. Biolog
[2]  
[Anonymous], 2009, WEEKLY EPIDEMIOLOGIC, V84, P133
[3]  
[Anonymous], 2010, GLOB POL ER STRAT PL
[4]  
[Anonymous], 2009, WEEKLY EPIDEMIOLOGIC, V84, P110
[5]  
[Anonymous], 2009, MOBRIDITY MORTALITY, V58, P1002
[6]   Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia [J].
Blomqvist, S ;
Savolainen, C ;
Laine, P ;
Hirttiö, P ;
Lamminsalo, E ;
Penttilä, E ;
Jöks, S ;
Roivainen, M ;
Hovi, T .
JOURNAL OF VIROLOGY, 2004, 78 (09) :4876-4883
[7]  
Bundesamt fur Gesundheit, 2007, B BAG, V46, P824
[8]   Isolation of vaccine-derived polioviruses in the Slovak Republic [J].
Cernáková, B ;
Sobotová, Z ;
Rovny, I ;
Bláhova, S ;
Roivainen, M ;
Hovi, T .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (06) :438-439
[9]   Interrupting wild poliovirus transmission using oral poliovirus vaccine: Environmental surveillance in high-risks area of India [J].
Chowdhary, Rashmi ;
Dhole, T. N. .
JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (08) :1477-1488
[10]   Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in greece [J].
Dedepsidis, Evaggelos ;
Kyriakopoulou, Zaharoula ;
Pliaka, Vaia ;
Kottaridi, Christine ;
Bolanaki, Eugenia ;
Levidiotou-Stefanou, Stamatina ;
Komiotis, Dimitri ;
Markoulatos, Panayotis .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2007, 73 (21) :6697-6704